thechronicle.net.au
Western Australia

Sisram Medical Ltd. to Hold First Half 2022 Financial Results Conference Call on August 22 at 8:30 a.m. ET

  • Written by The Chronicle


Members of Sisram Medical’s management team and board of directors will host a conference call to discuss the first half financial results in more detail on Monday, August 22, 2022, at 8:30 a.m. Eastern Time. Speakers will include Mr. Liu YI, Sisram’s Chairman and Executive Director, and Mr. Lior DAYAN, Sisram’s Chief Executive Officer, Mr. Guojun BU, Sisram’s CFO, Mr. Doron YANNAI, Alma’s CFO, Ms. Qianli FANG, Sisram’s Company Secretary, Investment & IR Director, following the prepared remarks they will also be available for a Q&A session.

The Company encourages participants to pre-register for the conference call using the follow link: https://AlmaLasers.activetrail.biz/Sisram-IR-form. Callers will receive dial-in details upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.

The conference call will be commenced at:

8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time

A replay will also be available on Sisram Medical’s Event’s page at: https://sisram-medical.com/investors/events-presentations/.

Hashtag: #SisramMedical

The issuer is solely responsible for the content of this announcement.

About Sisram Medical Ltd

Sisram Medical Ltd () is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics devices, injectables therapy, aesthetic and digital dentistry, personal care and more. The company is majority-owned by Fosun Pharma, one of China’s leading healthcare groups. On September 19, 2017, Sisram Medical went public, becoming the first Israeli company ever to trade on the Main Board of the Hong Kong Exchange.

Sisram Medical – Enhancing Quality of Life
Investor Relations Contact: